Women's Health Trial Tracker

Name: Women's Health Trial Tracker
Creator: 1 Women’s Health
License: United States government work; public domain unless the source record says otherwise.

Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records: 5,000
Last changed: 10/10/2026
Update schedule: 55 1 * * * UTC
Coverage: 05/26/2000–10/09/2026
Method: Methodology

Record	Record Date	Vuga Group	Change Status	Recency Days
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).	11/10/2021	INTERVENTIONAL	not-comparable	1,795.75
Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein)	11/11/2021	OBSERVATIONAL	not-comparable	1,794.75
Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture	11/11/2021	INTERVENTIONAL	not-comparable	1,794.75
Family Functioning in Obesity Treatment for Mexican Americans	11/15/2021	INTERVENTIONAL	not-comparable	1,790.75
Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV	11/16/2021	INTERVENTIONAL	not-comparable	1,789.75
Maternal & Offspring Microbiome Study	11/17/2021	INTERVENTIONAL	not-comparable	1,788.75
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)	11/17/2021	INTERVENTIONAL	not-comparable	1,788.75
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes	11/18/2021	INTERVENTIONAL	not-comparable	1,787.75
Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive	11/19/2021	OBSERVATIONAL	not-comparable	1,786.75
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer	11/22/2021	INTERVENTIONAL	not-comparable	1,783.75
Registry Platform Ovarian and Endometrial Cancer	11/22/2021	OBSERVATIONAL	not-comparable	1,783.75
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing	11/23/2021	INTERVENTIONAL	not-comparable	1,782.75
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery	11/23/2021	INTERVENTIONAL	not-comparable	1,782.75
Post-operative Cesarean Trial of Pain Control	11/23/2021	INTERVENTIONAL	not-comparable	1,782.75
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer	11/24/2021	INTERVENTIONAL	not-comparable	1,781.75
Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment	11/24/2021	INTERVENTIONAL	not-comparable	1,781.75
AN/BN Risk Factors Study	11/24/2021	OBSERVATIONAL	not-comparable	1,781.75
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You	11/26/2021	OBSERVATIONAL	not-comparable	1,779.75
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia	12/01/2021	INTERVENTIONAL	not-comparable	1,774.75
Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer	12/01/2021	INTERVENTIONAL	not-comparable	1,774.75
Conservative Management for PAS Pilot	12/01/2021	INTERVENTIONAL	not-comparable	1,774.75
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy	12/02/2021	INTERVENTIONAL	not-comparable	1,773.75
Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE)	12/02/2021	OBSERVATIONAL	not-comparable	1,773.75
Screening For BCRL In Targeted Therapy For Breast Cancer	12/03/2021	OBSERVATIONAL	not-comparable	1,772.75
Sickle Cell Disease Obstetric Multi-Disciplinary Care Programme	12/03/2021	OBSERVATIONAL	not-comparable	1,772.75
Twin Pregnancy Cohort	12/03/2021	OBSERVATIONAL	not-comparable	1,772.75
A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free Anesthesia	12/07/2021	INTERVENTIONAL	not-comparable	1,768.75
A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma	12/07/2021	INTERVENTIONAL	not-comparable	1,768.75
Investigation of PEMF Therapy for Female Patients With IC/BPS	12/08/2021	INTERVENTIONAL	not-comparable	1,767.75
Effect of Preoperative Oral Pregabalin Versus Intraoperative Fentanyl on Postoperative Analgesia	12/09/2021	INTERVENTIONAL	not-comparable	1,766.75
Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain	12/09/2021	INTERVENTIONAL	not-comparable	1,766.75
A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer	12/13/2021	INTERVENTIONAL	not-comparable	1,762.75
Sexual Dysfunction in Hypertensive Women	12/14/2021	INTERVENTIONAL	not-comparable	1,761.75
Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer	12/14/2021	INTERVENTIONAL	not-comparable	1,761.75
Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy	12/15/2021	OBSERVATIONAL	not-comparable	1,760.75
Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer	12/16/2021	INTERVENTIONAL	not-comparable	1,759.75
Prophylactic Mastectomy: Prospective Evaluation of the Correlation Between Skin Flap Thickness, Residual Glandular Tissue and Skin Necrosis by Imaging and Clinical Examination	12/17/2021	OBSERVATIONAL	not-comparable	1,758.75
Female Asian Nonsmoker Screening Study	12/21/2021	OBSERVATIONAL	not-comparable	1,754.75
Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity	12/21/2021	INTERVENTIONAL	not-comparable	1,754.75
The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome	12/21/2021	INTERVENTIONAL	not-comparable	1,754.75
Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial	12/21/2021	INTERVENTIONAL	not-comparable	1,754.75
Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction	12/27/2021	OBSERVATIONAL	not-comparable	1,748.75
Post-market Clinical Follow-up of the SRS Implant	12/27/2021	OBSERVATIONAL	not-comparable	1,748.75
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring	12/27/2021	OBSERVATIONAL	not-comparable	1,748.75
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer	12/29/2021	INTERVENTIONAL	not-comparable	1,746.75
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)	12/30/2021	INTERVENTIONAL	not-comparable	1,745.75
Casea S Contraceptive Implants (Casea S) Trial	01/03/2022	INTERVENTIONAL	not-comparable	1,741.75
Nutritional Intervention for Endometriosis	01/03/2022	INTERVENTIONAL	not-comparable	1,741.75
Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia	01/04/2022	INTERVENTIONAL	not-comparable	1,740.75
Mifepristone Outpatient Labour Induction	01/04/2022	INTERVENTIONAL	not-comparable	1,740.75